32469-24-2Relevant articles and documents
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins
Xu, Jun,Lee, Steve Seung-Young,Seo, Howon,Pang, Liang,Jun, Yearin,Zhang, Ruo-Yu,Zhang, Zhong-Yin,Kim, Pilhan,Lee, Wooin,Kron, Stephen J.,Yeo, Yoon
, (2018)
Current nanoparticle (NP) drug carriers mostly depend on the enhanced permeability and retention (EPR) effect for selective drug delivery to solid tumors. However, in the absence of a persistent EPR effect, the peritumoral endothelium can function as an a
QUINIC ACID-MODIFIED NANOPARTICLES AND USES THEREOF
-
Page/Page column 0112; 0116; 0117, (2018/12/03)
The present invention generally relates to targeted nanoparticle delivery to E-selectin- or P-selectin-positive cells or tissues. In particular, this invention discloses a method for preparing quinic acid-modified nanoparticles for targeted drug delivery
NOVEL CATIONIC AMPHIPHILES WITH QUINIC ACID HEAD-GROUPS FOR DNA VACCINATION
-
Page/Page column 15; 20, (2009/10/22)
The present invention provides a novel series of glycomimicking cationic amphiphiles containing quinic acid head-groups and methods for preparing the said cationic amphiphiles. The invention provides novel compositions containing the said amphiphiles with